Entheon Biomedical Corp.
ENTBF
$0.081
-$0.0035-4.14%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.90K | -47.20K | -69.40K | -55.70K | -53.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -3.90K |
| Change in Net Operating Assets | -6.00K | -4.30K | -2.70K | -14.80K | 23.70K |
| Cash from Operations | -67.00K | -51.50K | -72.10K | -70.50K | -34.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 6.90K |
| Cash from Investing | -- | -- | -- | -- | 6.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 147.50K | -- | -- |
| Repurchase of Common Stock | -147.50K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 147.50K | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 108.20K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.00K | -51.50K | 36.10K | -70.50K | -27.20K |